Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New treatment strategy for Parkinson's disease introduced

Sep. 13, 1996

New formulation of selegiline

Sep. 13, 1996

Dopaminergic agents claimed by Sandoz

Sep. 13, 1996

A major breakthrough in the treatment of schizophrenia

Sep. 13, 1996

New compounds from Roche with affinity for benzodiazepine receptors

Sep. 13, 1996

Merck & Co. synthesizes dopamine D4 receptor ligands

Sep. 13, 1996

Divestment of antimigraine treatment from Glaxo Wellcome to Zeneca

Sep. 13, 1996

Controlled-release oral analgesic formulation claimed by Euroceltique

Sep. 13, 1996

Chiron describes a new opiate receptor ligand

Sep. 13, 1996

Delta-opioid agonists for pain

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...